Literature DB >> 24100657

Enhanced inducible costimulator ligand (ICOS-L) expression on dendritic cells in interleukin-10 deficiency and its impact on T-cell subsets in respiratory tract infection.

Xiaoling Gao1, Lei Zhao1, Shuhe Wang1, Jie Yang1, Xi Yang1.   

Abstract

An association between inducible costimulator ligand (ICOS-L) expression and interleukin (IL)-10 production by dendritic cells (DCs) has been commonly found in infectious disease. DCs with higher ICOS-L expression and IL-10 production are reportedly more efficient in inducing regulatory T cells (Tregs). Here we use the Chlamydia muridarum (Cm) lung infection model in IL-10 knockout (KO) mice to test the relationship between IL-10 production and ICOS-L expression by DCs. We examined ICOS-L expression, the development of T-cell subsets, including Treg, Th17 and Th1 cell, in the background of IL-10 deficiency and its relationship with ICOS-L/ICOS signaling after infection. Surprisingly, we found that the IL-10 KO mice exhibited significantly higher ICOS-L expression by DCs. Moreover, IL-10 KO mice showed lower Tregs but higher Th17 and Th1 responses, but only the Th17 response depended on ICOS signaling. Consistently, most of the Th17 cells were ICOS⁺, whereas most of the Th1 cells were ICOS⁻ in the infected mice. Furthermore, neutralization of IL-17 in IL-10 KO mice significantly exacerbated lung infection. The data suggest that ICOS-L expression on DC may be negatively regulated by IL-10 and that ICOS-L expression on DC in the presence or absence of IL-10 costimulation may promote Treg or Th17 response, without significant impact on Th1.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24100657      PMCID: PMC3883961          DOI: 10.2119/molmed.2013.00035

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  58 in total

1.  Importance of ICOS-B7RP-1 costimulation in acute and chronic allograft rejection.

Authors:  E Ozkaynak; W Gao; N Shemmeri; C Wang; J C Gutierrez-Ramos; J Amaral; S Qin; J B Rottman; A J Coyle; W W Hancock
Journal:  Nat Immunol       Date:  2001-07       Impact factor: 25.606

2.  ICOS is essential for effective T-helper-cell responses.

Authors:  A Tafuri; A Shahinian; F Bladt; S K Yoshinaga; M Jordana; A Wakeham; L M Boucher; D Bouchard; V S Chan; G Duncan; B Odermatt; A Ho; A Itie; T Horan; J S Whoriskey; T Pawson; J M Penninger; P S Ohashi; T W Mak
Journal:  Nature       Date:  2001-01-04       Impact factor: 49.962

3.  ICOS is critical for CD40-mediated antibody class switching.

Authors:  A J McAdam; R J Greenwald; M A Levin; T Chernova; N Malenkovich; V Ling; G J Freeman; A H Sharpe
Journal:  Nature       Date:  2001-01-04       Impact factor: 49.962

4.  ICOS co-stimulatory receptor is essential for T-cell activation and function.

Authors:  C Dong; A E Juedes; U A Temann; S Shresta; J P Allison; N H Ruddle; R A Flavell
Journal:  Nature       Date:  2001-01-04       Impact factor: 49.962

Review 5.  Immunity to murine chlamydial genital infection.

Authors:  Richard P Morrison; Harlan D Caldwell
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

6.  Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity.

Authors:  Omid Akbari; Gordon J Freeman; Everett H Meyer; Edward A Greenfield; Tammy T Chang; Arlene H Sharpe; Gerald Berry; Rosemarie H DeKruyff; Dale T Umetsu
Journal:  Nat Med       Date:  2002-07-29       Impact factor: 53.440

7.  Chlamydia trachomatis mouse pneumonitis lung infection in IL-18 and IL-12 knockout mice: IL-12 is dominant over IL-18 for protective immunity.

Authors:  H Lu; X Yang; K Takeda; D Zhang; Y Fan; M Luo; C Shen; S Wang; S Akira; R C Brunham
Journal:  Mol Med       Date:  2000-07       Impact factor: 6.354

8.  The costimulatory molecule ICOS plays an important role in the immunopathogenesis of EAE.

Authors:  J B Rottman; T Smith; J R Tonra; K Ganley; T Bloom; R Silva; B Pierce; J C Gutierrez-Ramos; E Ozkaynak; A J Coyle
Journal:  Nat Immunol       Date:  2001-07       Impact factor: 25.606

Review 9.  Role of cytokines in Chlamydia trachomatis protective immunity and immunopathology.

Authors:  Xi Yang
Journal:  Curr Pharm Des       Date:  2003       Impact factor: 3.116

10.  IL-17A synergizes with IFN-γ to upregulate iNOS and NO production and inhibit chlamydial growth.

Authors:  Yongci Zhang; Haiping Wang; Jianyun Ren; Xiaofei Tang; Ye Jing; Donghong Xing; Guosheng Zhao; Zhi Yao; Xi Yang; Hong Bai
Journal:  PLoS One       Date:  2012-06-20       Impact factor: 3.240

View more
  10 in total

Review 1.  Contribution of dendritic cells to the autoimmune pathology of systemic lupus erythematosus.

Authors:  Juan P Mackern-Oberti; Carolina Llanos; Claudia A Riedel; Susan M Bueno; Alexis M Kalergis
Journal:  Immunology       Date:  2015-10-12       Impact factor: 7.397

Review 2.  Cell-surface molecule-mediated cell-cell interactions in the regulation of ILC2-driven allergic inflammation.

Authors:  Aihua Lei; Jie Zhou
Journal:  Cell Mol Life Sci       Date:  2019-07-16       Impact factor: 9.261

3.  [Role of inducible costimulatory molecule-mediated Th17 cell polarization in renal fibrosis in spontaneously hypertensive rats].

Authors:  Yu Wang; Bo-Shi Wang; Xu Hui; Jun Qiao; Wei-Zhen Li; Nan Sun
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-05-20

4.  The Combination of MBP and BCG-Induced Dendritic Cell Maturation through TLR2/TLR4 Promotes Th1 Activation In Vitro and Vivo.

Authors:  LiNa Jiang; GuoMu Liu; WeiHua Ni; NanNan Zhang; Jing Jie; Fei Xie; GuiXiang Tai
Journal:  Mediators Inflamm       Date:  2017-02-15       Impact factor: 4.711

5.  Weissella cibaria WIKIM28 ameliorates atopic dermatitis-like skin lesions by inducing tolerogenic dendritic cells and regulatory T cells in BALB/c mice.

Authors:  Seul Ki Lim; Min-Sung Kwon; Jieun Lee; Young Joon Oh; Ja-Young Jang; Jong-Hee Lee; Hae Woong Park; Young-Do Nam; Myung-Ji Seo; Seong Woon Roh; Hak-Jong Choi
Journal:  Sci Rep       Date:  2017-01-09       Impact factor: 4.379

6.  Intercepting Premalignant, Preinvasive Breast Lesions Through Vaccination.

Authors:  Nadia Nocera Zachariah; Amrita Basu; Namrata Gautam; Ganesan Ramamoorthi; Krithika N Kodumudi; Nagi B Kumar; Loretta Loftus; Brian J Czerniecki
Journal:  Front Immunol       Date:  2021-11-24       Impact factor: 7.561

7.  Immunomodulating effects of the anti-viral agent Silibinin in liver transplant patients with HCV recurrence.

Authors:  Antonino Castellaneta; Antonio Massaro; Maria Rendina; Francesca D'Errico; Sonia Carparelli; Salvatore Fabio Rizzi; Angus W Thomson; Alfredo Di Leo
Journal:  Transplant Res       Date:  2016-01-20

8.  CpG ODN1826 as a Promising Mucin1-Maltose-Binding Protein Vaccine Adjuvant Induced DC Maturation and Enhanced Antitumor Immunity.

Authors:  Jing Jie; Yixin Zhang; Hongyue Zhou; Xiaoyu Zhai; Nannan Zhang; Hongyan Yuan; Weihua Ni; Guixiang Tai
Journal:  Int J Mol Sci       Date:  2018-03-20       Impact factor: 5.923

9.  Porcine Circovirus Type 2 Rep Enhances IL-10 Production in Macrophages via Activation of p38-MAPK Pathway.

Authors:  Xingchen Wu; Xiaoya Wang; Tengfei Shi; Le Luo; Dan Qiao; Zhenyu Wang; Cong Han; Qian Du; Dewen Tong; Yong Huang
Journal:  Viruses       Date:  2019-12-10       Impact factor: 5.048

10.  Escherichia coli Heat-Labile Enterotoxin B Subunit Combined with Ginsenoside Rg1 as an Intranasal Adjuvant Triggers Type I Interferon Signaling Pathway and Enhances Adaptive Immune Responses to an Inactivated PRRSV Vaccine in ICR Mice.

Authors:  Fei Su; Yige Wu; Junxing Li; Yee Huang; Bin Yu; Lihua Xu; Yin Xue; Chenwen Xiao; Xiufang Yuan
Journal:  Vaccines (Basel)       Date:  2021-03-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.